Dr. Tarver is the Chief Executive Officer of Vibe Pharmaceuticals LLC. He brings a strong record of management and leadership in dynamic scientific and business environments. Dr. Tarver currently serves as Chief Research Administrator in the Department of Medicine at the University of Pennsylvania. In his prior role at the University of Pennsylvania, he was Executive Director in the Department of Chemistry.
Dr. Tarver spent 9 years at Lexicon Pharmaceuticals, Inc. where he began as a research scientist and ended as Associate Director in the Medicinal Chemistry department. He is an experienced research manager with a breadth of knowledge in drug discovery R&D, with particular focus on bone disease and immunology, and is vastly experienced with scientific talent recruiting. He is an inventor of several preclinical candidates for osteoporosis and has recently authored several papers and presentations on the topic.
Dr. Tarver has a Ph.D. in Organic Chemistry from the University of Pennsylvania, an M.B.A. from the Fox School of Business at Temple University, and a B.S. in Chemistry & Mathematics from Morehouse College.
Robert pignolo, MD, PhD
Dr. Pignolo is the Founder and Chief Scientific Officer of Vibe Pharmaceuticals. He also currently serves as chair of the Division of Geriatric Medicine and Gerontology, Department of Internal Medicine at Mayo Clinic in Minnesota. He holds joint appointments as senior associate consultant in the Division of Hospital Internal Medicine; the Division of Endocrinology, Diabetes, Metabolism, Nutrition; and the Department of Physiology and Biomedical Engineering. Dr. Pignolo also serves as director of the Translation and Pharmacology Program at the Robert and Arlene Kogod Center on Aging, and director of the Center for Clinical and Translational Science Pilot Translational and Clinical Studies Program. He joined the staff of Mayo Clinic in 2016 and is recognized with the distinction of the Robert and Arlene Kogod Professorship in Geriatric Medicine.Dr. Pignolo earned his bachelor’s degree in biochemistry and doctorate degree in molecular biology at the University of Pennsylvania. He earned his medical degree at Medical College of Pennsylvania and Hahnemann University, where he also completed a postdoctoral fellowship at the Center for Gerontological Research in addition to his internship and residency in medicine. He subsequently completed a fellowship in geriatric medicine and a postdoctoral fellowship in the McKay Laboratory of Orthopaedic Surgery Research at the University of Pennsylvania. Dr. Pignolo is a nationally recognized leader and expert in geriatric medicine. His major research accomplishments are in the areas of skeletal aging, stem cell biology and regenerative medicine informed by rare genetic disorders of extraskeletal bone formation. His research in cellular senescence and bone is closely aligned with the Cellular Senescence and Aging Bone and Muscle programs of the Robert and Arlene Kogod Center on Aging.
Prior to joining Mayo Clinic, Dr. Pignolo served as associate professor of medicine at the Hospital of the University of Pennsylvania and the Presbyterian Medical Center of Philadelphia, University of Pennsylvania School of Medicine; associate professor of Orthopaedic Surgery at the University of Pennsylvania School of Medicine; and director of Ralston-Penn Clinic for Osteoporosis and Related Bone Disorders. In addition, he directed the Histology Core in the Penn Center for Musculoskeletal Disorders, for which he was one of the principal investigators on a P30 award from the National Institutes of Health.
In recognition of his work, Dr. Pignolo has received many awards and honors, including the Distinguished Service Award in Molecular Orthopaedics, conferred by the University of Pennsylvania Health System; the Early Career Excellence in Teaching Award, conferred by the American Society for Bone and Mineral Research; and the Ian Cali Distinguished Clinician-Scientist, conferred by the Center for Research in FOP and Related Disorders.
Dr. Pignolo’s memberships in professional organizations include the American Aging Association, American Geriatrics Society, American Society for Bone and Mineral Research, and Association of Osteobiology.
Patty Quinn McAuley
Patty Quinn McAuley is the Chief Marketing Officer for Vibe Pharmaceuticals. In this role, she is responsible for leading the marketing and communications efforts of the company.
She has held various senior sales and marketing positions in the pharmaceutical, asset management, and luxury goods industries and has a proven record of helping companies achieve growth through product positioning, corporate branding and sales and marketing campaign execution. She currently holds the position of Director of Management at Clark Capital Management Group, a Philadelphia-based independent asset manager.
Patty earned her MBA at the Fox School of Business at Temple University, and holds the Certified Financial Planner designation, FINRA Series 7 and Series 66 licenses. She graduated summa cum laude from New York University with a B.S. in Mass Media Communications.
Upstart at the university of pennsylvania
As a division of the Penn Center for Innovation at the University of Pennsylvania, UPstart represents a virtual incubator with hands-on support to companies generated from research at the University of Pennsylvania and offers a wide array of services to assist entrepreneurial faculty members in the company formation and development process. Since 2010, UPstart has worked with nearly 100 faculty and staff members to form and launch new companies based on inventions in the life sciences, materials and information technologies space. UPstart maintains a portfolio of about 70 active companies.